Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam and Cyclobenzaprine Combination for Acute Lumbago
NCT01587508Phase 3Withdrawn
- Sponsor
- Eurofarma
- Start
- May 2013
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of meloxicam + cyclobenzaprine in acute lumbago (3 arms), sponsored by Eurofarma. Primary endpoint: Pain Reduction at 3 days. Planned start May 2013; status: withdrawn.
02
Drugs
meloxicam + cyclobenzaprine
03
Conditions
acute lumbago
Beyond the preview
Go deeper on NCT01587508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01587508.